04/16/2026 14:00
Textron Aviation Expands High‑Speed Cabin Connectivity With Gogo 5G Upgrade for Cessna Citation Business Jets

Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the availability of Gogo 5G, a new connectivity upgrade that gives Citation operators faster speeds, lower latency and improved WiFi performance in the cabin. The aftermarket solution is now offered for the Cessna Citation Longitude, X+, X, Sovereign+, Sovereign, Latitude, XLS Gen2, XLS+, XLS and Excel, following the issuance of the Federal Aviation Administration’s (FAA) Supplemental Type Certificate (STC). Customers ca...

AFP’s financial results 2025: positive net profit for the seventh straight year despite a first decline in commercial sales since 2018

AFP’s board approved the 2025 accounts at its meeting of April 16, 2026.

AFP’s board approved the 2025 accounts at its meeting of April 16, 2026.
Anglais
04/16/2026 17:55
Multi-Color Corporation Announces Confirmation of Plan of Reorganization

Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that the United States Bankruptcy Court for the District of New Jersey (the “Court”) has confirmed the Company’s prepackaged plan of reorganization (the “Plan”). MCC expects to emerge from prepackaged Chapter 11 in the coming weeks. Under the terms of the Plan, MCC will complete a comprehensive restructuring transaction that significantly deleverages the Company’s balance sheet and reca...

04/16/2026 20:04
BTG Pactual Timberland Investment Group Completes First Close of US$ 370 Million to Newest Core Latin American Timberland Strategy

BTG Pactual Timberland Investment Group (BTG Pactual TIG), one of the world’s largest timberland investment managers, announced today that it has completed the first close of US$ 370 million in commitments to its newest core Latin America strategy. Targeting investment of US$ 1.5 billion over 5 years, the strategy focuses on large-scale, sustainably managed, core timberland assets across Chile, Uruguay and Brazil, and seeks diversification across geography, climatic zones, species, and end-ma...

04/17/2026 06:00
Samsung Bioepis Highlights Consistent Efficacy of SB16 (OBODENCE®; Denosumab) Across Osteoporosis Patient Subgroups at WCO-IOF-ESCEO 2026

Samsung Bioepis Co., Ltd. announced today new data supporting consistent efficacy of SB16 (OBODENCE®1), a biosimilar to Prolia2 (denosumab) across patient subgroups compared to the reference denosumab. The data will be presented as a poster presentation at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) 2026 in Prague from April 16 to 19. “Consistent efficacy across patient subgroups is critical in reinforcing physician confidence and advancing ...